- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01743105
Reproductibility of TM-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the ER (EDDRA-Repro)
November 14, 2025 updated by: Centre Hospitalier Universitaire de Nīmes
Reproductibility of Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the Emergency Room
The main objective of this study is to evaluate the inter-rater reproducibility of diaphragmatic excursion measures via time-motion-mode ultrasound (evaluation performed on the first measure) in patients experiencing acute respiratory distress emergencies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The secondary objectives of this study are:
- To assess the feasibility of measuring the diaphragmatic excursion in the context of emergency management (ratio of measured patients / included patients).
- To evaluate the time required for the measurement.
- To assess the intra-rater reproducibility of measurements of diaphragmatic excursion (comparison of first and second measures).
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gard
-
Nîmes, Gard, France, 30029
- CHU de Nimes - Hopital Universitaire Caremeau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient has acute respiratory distress defined by a respiratory rate > 25, and / or signs of struggle and hypoxia, oxygen saturation (SpO2) <90% and / or pH <7.35 and carbon dioxide partial pressure (pCO2) > 6 kPa (45 mm Hg)
- The patient breathes spontaneously (no respirator)
Exclusion Criteria:
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient or his/her representative refuses to sign the consent
- It is impossible to correctly inform the patient, or to correctly inform his/her representative
- The patient is pregnant, parturient, or breastfeeding
- The patient has a neurological or neuromuscular disease that modifies diaphragm function/movement; this does not include cases of decompensation (polyradiculoneuropathy, Lou Gehrig's disease, Myasthenia ...).
- Patient admitted with respiratory support treatment in progress
- Patient admitted with respiratory failure requiring immediate implementation of mechanical ventilation, thus preventing ultrasound measurements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study population
The study population consists of patients treated for acute respiratory distress in the emergency department at the Nîmes University Hospital. See inclusion and exclusion criteria. Interventions: Diaphragm excursion measures 1, Diaphragm excursion measures 2 |
A first diaphragm ultrasound study will be carried out by investigator 1.
A Vivid S6 GE Ultrasound will be used, with a phased array cardiac probe.
A second diaphragm ultrasound study will be carried out immediately after Ultrasound 1, and by investigator 2. The results are blinded between investigators.
A Vivid S6 GE Ultrasound will be used, with a phased array cardiac probe.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragmatic excursion, first measure by investigator 1
Time Frame: Baseline (day 0)
|
in centimeters
|
Baseline (day 0)
|
|
Diaphragmatic excursion, first measure by investigator 2
Time Frame: Baseline (day 0)
|
in centimeters
|
Baseline (day 0)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time necessary to measure diaphragm movement amplitude (minutes)
Time Frame: Baseline (day 0)
|
Baseline (day 0)
|
|
|
Feasibility (yes/no)
Time Frame: Baseline (day 0)
|
We were able to perform the required measurements (yes/no)
|
Baseline (day 0)
|
|
Diaphragmatic excursion, second measure by investigator 1
Time Frame: Baseline (day 0)
|
(centimeters)
|
Baseline (day 0)
|
|
Diaphragmatic excursion, second measure by investigator 2
Time Frame: Baseline (day 0)
|
(centimeters)
|
Baseline (day 0)
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Age
Time Frame: Baseline (day 0)
|
Baseline (day 0)
|
|
Sexe
Time Frame: Baseline (day 0)
|
Baseline (day 0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Xavier Bobbia, MD, Centre Hospitalier Universitaire de Nīmes
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
January 27, 2014
Study Completion (Actual)
January 27, 2014
Study Registration Dates
First Submitted
December 4, 2012
First Submitted That Met QC Criteria
December 5, 2012
First Posted (Estimated)
December 6, 2012
Study Record Updates
Last Update Posted (Estimated)
November 17, 2025
Last Update Submitted That Met QC Criteria
November 14, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOCAL/2012/XBAC-01
- 2012-A01094-39 (Other Identifier: RCB number)
- Bobbia EDDRA Repro (Other Identifier: BESPIM, Nîmes University Hospital)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome, Adult
-
Wolfson Medical CenterUnknown
-
Centre Hospitalier Universitaire de NiceCompletedRespiratory Distress Syndrome,AdultFrance
-
Abbott NutritionTerminatedAcute Lung Injury | Respiratory Distress Syndrome,AdultRussian Federation
-
GlaxoSmithKlineTerminatedLung Injury, Acute and Respiratory Distress Syndrome, AdultUnited Kingdom
-
Amazon UniversitySanta Casa de Misericórdia do ParáCompletedSepsis | HELLP Syndrome | Postpartum Period | Respiratory Distress Syndrome,Adult
-
Michael A. MatthayThe University of Texas Health Science Center, Houston; United States Department... and other collaboratorsCompletedRespiratory Distress Syndrome, AdultUnited States
-
Dompé Farmaceutici S.p.ACompletedAcute Respiratory Distress Syndrome, AdultUnited States, Italy, Germany
-
Implicit BioscienceUniversity of WashingtonRecruitingAcute Respiratory Distress Syndrome | Acute Lung Injury | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Adult Respiratory Distress SyndromeUnited States
-
Faron Pharmaceuticals LtdSeventh Framework ProgrammeTerminatedRespiratory Distress Syndrome, AdultSpain, United Kingdom, France, Italy, Finland, Czechia, Belgium, Germany
-
Karolinska University HospitalKarolinska InstitutetUnknownAcute Respiratory Distress Syndrome, AdultSweden
Clinical Trials on Diaphragm excursion measures 1
-
Marmara University Pendik Training and Research...CompletedIntubation; Difficult or FailedTurkey (Türkiye)
-
Institut PasteurInstitut de l'AuditionRecruiting
-
Universidade Federal do CearaCompleted
-
Lungpacer Medical Inc.SyntactxCompletedVentilator Induced Diaphragm DysfunctionUnited States
-
Ege UniversityActive, not recruitingGastrointestinal Motility Disorder | Pelvic Floor Dyssynergia | Distension; Bowel | Gastrointestinal System Disease | Functional BloatingTurkey
-
Hospices Civils de LyonCompletedChronic HemolysisFrance
-
Fundación de Investigación Biomédica - Hospital...Recruiting
-
Hoffmann-La RocheActive, not recruitingCarcinoma, Non-Small-Cell LungFrance, Spain, China, Croatia, Thailand, Netherlands, Germany, Brazil, Lebanon, Mexico, Jordan, Greece, Slovakia, Sweden, Italy, India, Romania, Turkey (Türkiye)
-
Medical University of ViennaNot yet recruiting
-
Lee's Pharmaceutical LimitedZhaoke (Guangzhou) Pharmaceutical LimitedCompletedBioequivalence of Two Azilsartan FormulationsHong Kong